Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001415889-25-003613

Options or other derivatives

  • CBO, COO and CCO acquired 450,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Hannah Brendan CBO, COO and CCO 2025-01-28 Grant or award · Employee Stock Option (right to buy) +450,000 450,000 D
Loading xslF345X05/form4-02112025_100238.xml…